Table 4 Association between NRCII and risk of ACS after excluding patients with prior lipid-lowering therapy: sensitivity analysis results.

From: Association of the novel remnant cholesterol inflammatory index with acute coronary syndrome risk in hospitalized patients with diabetes: a two-center study

Characteristic

Crude model

Model 1

Model 2

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

NRCII

1.21 (1.16,1.26)

< 0.001

1.21 (1.16,1.26)

< 0.001

1.21 (1.12,1.31)

< 0.001

Q1

Reference

 

Reference

 

Reference

 

Q2

1.42 (1.10,1.84)

0.01

1.4 (1.07,1.83)

0.01

1.38 (0.93,2.04)

0.11

Q3

2.13 (1.66,2.74)

< 0.001

1.99 (1.54,2.58)

< 0.001

2.26 (1.52,3.37)

< 0.001

Q4

2.85 (2.24,3.64)

< 0.001

2.74 (2.13,3.53)

< 0.001

2.85 (1.86,4.37)

< 0.001

P for trend

< 0.001

 

< 0.001

 

< 0.001

  1. Crude model: unadjusted; included only the exposure variable NRCII.
  2. Model 1: adjusted for age, sex, race, education level, and marital status.
  3. Model 2: adjusted for age, sex, race, education level, marital status, smoking status, alcohol consumption, BMI, hypertension, TG, SCR, and UA.
  4. NRCII novel remnant cholesterol inflammatory index, ACS acute coronary syndrome, BMI body mass index, TG triglycerides, SCR serum creatinine, UA uric acid, OR odds ratio, CI confidence interval.
Back to article page